Welcome to the official corporate blog of Rx Review, LLC. Check here for the lastest news, insights, and comments from our company and our staff.
Subscribe to our corporate blog's rss feed.
Jakafi represents the first and only FDA-Approved Treatment For Myeleofibrosis, a potentially life-threatening blood cancer. It is great to see pharmaceutical companies think ahead and provide patient assistance programs for uninsured and under-insured patients to receive the help they need to receive expensive treatments. People with MF have few treatment options, expensive or not. It is a progressive and eventually life-threatening blood cancer. More information on the product and the company can be found here.
Terms of Service/Legal
Copyright 2012 RX Review Service LLC, all rights reserved. The Rx Review name and logo are tradermarks of Rx Review Service, LLC. All other logos and trademarks are the property of the respective trademark owners.